Načítá se...

Up-regulation of hypoxia-inducible factor antisense as a novel approach to treat ovarian cancer

Ovarian cancer (OC) is estimated to kill ~14,000 women in the United States in 2019. Current chemotherapies to treat OC initially show therapeutic efficacy but frequently drug resistance develops, at which point therapies with alternative targets are needed. Herein, we are describing a novel approac...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Theranostics
Hlavní autoři: Lu, Tiangong, Tang, Jianming, Shrestha, Binita, Heath, Blake R., Hong, Li, Lei, Yu L., Ljungman, Mats, Neamati, Nouri
Médium: Artigo
Jazyk:Inglês
Vydáno: Ivyspring International Publisher 2020
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7295058/
https://ncbi.nlm.nih.gov/pubmed/32550915
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.41792
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!